Abstract:Ethnopharmacological relevance: Danshen (Salvia miltiorrhiza Bunge) is widely used in traditional Chinese medicine (TCM), often in combination with other herbs, to treat a diversity of ailments. More recent studies have focused on its possible roles in the treatment of respiratory diseases (pneumonia and pulmonary fibrosis) and found that it has pharmacological activity that protects pulmonary morphology and function. However, the mechanism underlying this activity has not yet been clarified.Materials and methods: The purpose of this study was to investigate the anti-pulmonary fibrosis effects exerted by salvianolic acid A (SAA), the ingredient responsible for the pharmacological activity of Danshen, and the underlying mechanisms. Bleomycin (BLM)-induced rat pulmonary fibrosis was used to evaluate the antifibrotic role of SAA, and fibroblast cells were used to study the mechanism involved.Results: BLM-treated rats exhibited increased alveolar wall thickness and collagen deposition in lung tissues, but these pathologies were greatly attenuated by daily administration of SAA. We also found that SAA significantly inhibited the proliferation, adhesion and migration of fibroblasts in vitro. This was partly due to a strong induction of cell cycle arrest and apoptosis upon SAA treatment. Consistent with these phenotypes, we observed decreased expression of the cell cycle-related proteins cyclin D1, cyclin El, and cyclin B1, and increased expression of p53 and p21 in SAA-treated cells. In addition, the antiapoptotic Bcl-2 protein decreased in a dose-dependent manner, while cleaved caspase-3 protein increased upon SAA treatment.Conclusions: These results suggest that the alleviation of rat pulmonary fibrosis by SAA is due to the inhibition of fibroblast proliferation and induction of apoptosis, which occurs mainly through p53-dependent growth arrest and apoptosis. We suggest that SAA should be considered as a potential novel therapeutic agent for the treatment of fibrotic lung diseases. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

Sesamin Alleviates Asthma Airway Inflammation by Regulating Mitophagy and Mitochondrial Apoptosis.

Sesamin Attenuates Allergic Airway Inflammation Through the Suppression of Nuclear Factor-Kappa B Activation.

Sesamin attenuates inflammation response in a murine model of asthma

Sesamin Induces A549 Cell Mitophagy and Mitochondrial Apoptosis Via a Reactive Oxygen Species-Mediated Reduction in Mitochondrial Membrane Potential.

Sesamin Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Inhibition of TLR4 Signaling Pathways

Sesamin Attenuates Mast Cell-Mediated Allergic Responses by Suppressing the Activation of P38 and Nuclear Factor-Κb.

Anxiolytic Effects of Sesamin in Mice with Chronic Inflammatory Pain

Sesamin induces cell cycle arrest and apoptosis through the inhibition of signal transducer and activator of transcription 3 signalling in human hepatocellular carcinoma cell line HepG2.

(+)-Sesamin attenuates chronic unpredictable mild stress-induced depressive-like behaviors and memory deficits via suppression of neuroinflammation.

Sesamin ameliorates nonalcoholic steatohepatitis through inhibiting hepatocyte pyroptosis in vivo and in vitro

The influence of Hyssopus cuspidatus Boriss extract on lipid mediators metabolism network in asthmatic mice

Prevention of Pulmonary Fibrosis with Salvianolic Acid A by Inducing Fibroblast Cell Cycle Arrest and Promoting Apoptosis

Protective effects of sesamin on liver fibrosis through antioxidative and anti-inflammatory activities in rats

Sesamin Induces ER Stress-Mediated Apoptosis and Activates Autophagy in Cervical Cancer Cells

Sesquiterpene lactones from Xanthium sibiricum Patrin alleviate asthma by modulating the Th1/Th2 balance in a murine model

Sesamin Inhibits IL-1β-stimulated Inflammatory Response in Human Osteoarthritis Chondrocytes by Activating Nrf2 Signaling Pathway

Sesamin ameliorates lipopolysaccharide/d-galactosamine-induced fulminant hepatic failure by suppression of Toll-like receptor 4 signaling in mice.

Sesamin Activates Skeletal Muscle FNDC5 Expression and Increases Irisin Secretion via the SIRT1 Signaling Pathway

Sesamin Protects Against Cardiac Remodeling Via Sirt3/ROS Pathway.

Sesamin suppresses mast cell activation through inhibition of PKCα/NF-κB signaling pathway

Sesamin Attenuates Obesity-Associated Nonalcoholic Steatohepatitis in High-Fat and High-Fructose Diet-Fed Mice.